Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.

about

Lipoic Acid and Progesterone Alone or in Combination Ameliorate Retinal Degeneration in an Experimental Model of Hereditary Retinal Degeneration.

P2860

Q54940443-44D597AC-7315-4071-92FB-3491D62E9B95

P2860

Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.

Item

http://www.wikidata.org/entity/Q38978374

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tolerability in the elderly po ...... tioxidant therapy for the eye.

@en

type

Item

label

Tolerability in the elderly po ...... tioxidant therapy for the eye.

@en

prefLabel

Tolerability in the elderly po ...... tioxidant therapy for the eye.

@en

P1476

Tolerability in the elderly po ...... tioxidant therapy for the eye.

@en

P2093

Aaishah R Raquib

http://www.w3.org/2001/XMLSchema#string

Benjamin J Kim

http://www.w3.org/2001/XMLSchema#string

Daniel Sarezky

http://www.w3.org/2001/XMLSchema#string

Joshua L Dunaief

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.

Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.

Systemic administration of the antioxidant/iron chelator α-lipoic acid protects against light-induced photoreceptor degeneration in the mouse retina.

Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration.

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction.

The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation.

P304

1899-1903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S115900

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27729766

http://www.w3.org/2001/XMLSchema#string

P932

5047711

http://www.w3.org/2001/XMLSchema#string

Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.

about

P2860

P2860

Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932